A novel multipotent sigma 1/M1 muscarinic activator for a comprehensive therapeutic strategy in AD
- ANAVEX® Life Sciences Corp.
- Mar 26, 2014
- 1 min read
International Geneva/Springfield Symposium on Advances in Alzheimer Therapy (2014), Geneva, Switzerland
A. Fisher, R. Medeiros, N. Bar-Ner, N. Natan, R. Brandeis, H. Elkon, V. Nahum, G. Grigoryan, M. Segal and F. Laferla
